Journal of Evidence-Based Medicine 2012 Issue 2 Multi-Center Studies Barcelona Clinical Staging and Liver Cancer Patients Liver Transplant Survival Benefit Evaluation of Forecasting Models

Home | Survey | Payment| Talks & Presentations | Job Opportunities

Journals A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Journal of Evidence-Based Medicine
1671-5144
2012 Issue 2

Multi-Center Studies Barcelona Clinical Staging and Liver Cancer Patients Liver Transplant Survival Benefit Evaluation of Forecasting Models
ZHOU Jie;YANG Dong-yang

..............page:89-91,95

Meta-Analysis of Ordinal Data and Its Solution by SAS
ZHANG Tian-song;XIONG Qian

..............page:125-128

The Safety and Efficacy of High-Dose Proton Beam Radiotherapy for Hepatocellular Carcinoma:A Phase Ⅱ Prospective Trial
LI Wei-xiong;ZENG Zi-jun

..............page:103-105

xin xi dong tai

..............page:81-84,88,105

An Interview at 2012 Chinese Lung Cancer Summit Forum
YU Lin;ZHANG Hua

..............page:70-81

A Meta-Analysis of Association of Mycoplasma Fermentans and HIV Infection
JIN Hui;GAO Qian;WU Jian-ru;WANG Bei

..............page:112-116

Circulating MicroRNA-21 as A Novel Biomarker for Hepatocellular Carcinoma
HUANG Yuan-yuan;YANG Qiong;XIE De-rong;YANG Li-hui

..............page:109-111,124

Survival after Anatomic Resection Versus Nonanatomic Resection for Hepatocellular Carcinoma:A Meta-Analysis
JIAN Zhi-xiang;JIN Hao-sheng

..............page:96-98

Systematic Review of GLP-1 Analogues—Liraglutide for Type 2 Diabetes Mellitus
YAN Xin;DENG Hong-ming;XIAO Chang-qing

..............page:117-124

Systematic Review of Survival and Disease Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
GUO Rong-ping;LI Ying

..............page:92-95

The Consensus of Small Cell Lung Cancer Management

..............page:65-69

Comparation of Doxorubicin plus Sorafenib to Doxorubicin Alone in Patients with Advanced Hepatocellular Carcinoma
MA Dong;DONG Qiu-mei;LIU Jian-hua

..............page:106-108

New Progress in Treatment of Primary Hepatocellular Carcinoma
OU Jin-rui;WANG Hui-ling

..............page:85-88

Phase Ⅲ Study of Sorafenib after Transarterial Chemoembolisation in Japanese and Korean Patients with Unresectable Hepatocellular Carcinoma
MENG Qing-wen;LU Li-gong

..............page:99-102